Dextromethorphan and guaifenesin use need to be monitored very carefully in patients with "bad metabolizer" CYP2D6 enzyme levels and people who will be sedated. This combination medication provides a big median harmful dose (TD50) to median efficient dose (ED50) ratio (or therapeutic index) in these individuals. Delsym has a complete https://monkeys-for-sale24456.elbloglibre.com/30090922/dextromethorphan-dxm-for-sale-in-germany-can-be-fun-for-anyone